Ketogenic diet in epilepsy: an updated review

Publications

Share / Export Citation / Email / Print / Text size:

Journal of Epileptology

Foundation of Epileptology

Subject: Medicine

GET ALERTS

ISSN: 2299-9728
eISSN: 2300-0147

DESCRIPTION

8
Reader(s)
15
Visit(s)
0
Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Archive
Volume 26 (2018)
Volume 25 (2017)
Volume 24 (2016)
Volume 23 (2015)
Volume 22 (2014)
Volume 21 (2013)
Related articles

VOLUME 26 , ISSUE 1 (June 2018) > List of articles

Ketogenic diet in epilepsy: an updated review

Magdalena Dudzińska

Keywords : ketogenic diet, epilepsy

Citation Information : Journal of Epileptology. VOLUME 26 , ISSUE 1 , ISSN (Online) 2300-0147, DOI: 10.21307/jepil-2018-004, June 2018 © 2018.Copyright and photocopying by Foundation of Epileptology, 2018

License : (BY-NC-ND 4.0)

Received Date : 04-June-2018 / Accepted: 27-August-2018 / Published Online: 30-August-2018

ARTICLE

ABSTRACT

Introduction. Finding an effective epilepsy treatment has been a challenge in medicine for centuries. It is especially difficult to treat drug-resistant epilepsy, which accounts for 20–30% of epilepsy cases, even after the introduction of numerous new anti-epileptic drugs (AEDs). This gives an incentive to search for therapies other than pharmacotherapy, e.g. the ketogenic diet (KD).

Aim. The present review paper aims to present the current state of knowledge regarding the effectiveness of the KD, its mechanism of action, indications, method of treatment and potential adverse effects.

Material and method. The review covers relevant most recent (up to March 2018) papers using PubMed and Medline databases.

Results and discussion. The history of the KD dates back to ancient times. It was believed to be very promising at the beginning of the last century, but then was temporarily ‘forgotten’ and has been undergoing a second renaissance since around 1990. It is currently recognised in most countries. The KD is administered mainly to children but over the last few years there have been attempts to use it in adults as well. The theoretical basis of the diet consists in the fact that it ‘mimics’ the metabolic state of an organism subject to fasting by replacing the basic source of energy for the brain, that is glucose, with ketone bodies, which are a product of fat breakdown. In spite of scientific progress, the exact mechanism underlying the KD is still not known. Its effectiveness, at first mainly as an add-on therapy, and in some cases as the first-line monotherapy, is rated quite highly (>50% seizure reduction in >50% patients; of which in 20–30% of patients seizures are reduced by >90%). It can be used to treat all types of epileptic seizures after excluding contraindications. The KD, like any medical therapy for serious illnesses, may cause adverse effects. Most of them are mild, can be prevented, and if they occur, can be fairly easily treated

Conclusion. The KD as add-on therapy or as monotherapy is a medical treatment of epilepsy administered under medical supervision.

Content not available PDF Share

FIGURES & TABLES

REFERENCES

A. D. B.: The Ketogenic Diet in Epilepsy. Can. Med. Assoc. J., 1931, 24: 106–107.

Ahn W.K., Park S., Kim H.D.: Protein-Losing Enteropathy as a Complication of the Ketogenic Diet. Yonsei Med. J., 2017, 58: 891–893. doi: 10.3349/ymj.2017.58.4.891
[CROSSREF]

Appavu B., Vanatta L., Condie J., Kerrigan J.F., Jarrar R.: Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure, 2016, 41: 62–65. doi: 10.1016/j.seizure.2016.07.006

Archer J., Warren A.E.L., Jackson G.D., Abbott D.: Conceptualizing Lennox-Gastaut syndrome as a secondary network epilepsy. Front. Neurol., 2014, 5: 225. doi: 10.3389/ fneur.2014.00225

Arslan N., Guzel O., Kose E., Yılmaz U., Kuyum P., Aksoy B., Çalık T.: Is ketogenic diet treatment hepatotoxic for children with intractable epilepsy? Seizure, 2016, 43: 32–38. doi: 10.1016/j.seizure.2016.10.024.

Arsov T., Mullen S.A., Damiano J.A., Lawrence K.M., Huh L.L., Nolan M. et al.: Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia, 2012a, 53: e204– e207. doi: 10.1111/epi.12007.

Arsov T., Mullen S.A., Rogers S., Phillips A.M., Lawrence K.M., Damiano J.A. et al.: Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann. Neurol., 2012b, 72: 807–815. doi: 10.1002/ana.23702

Asadi-Pooya A.A.: Lennox-Gastaut syndrome: a comprehensive review. Neurol. Sci., 2018, 39: 403–414. doi: 10.1007/ s10072-017-3188-y

Ashrafi M.R., Hosseini S.A 39 Barañano K.W., Hartman A.L.: The Ketogenic Diet: in Epilepsy and Other Neurologic Illnesses. Curr. Treat. Options Neurol., 2008, 10: 410–419.

Bergqvist A.G.C.: Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res., 2012, 100: 258–260. doi:10.1016/j. epilepsyres.2011.04.009.

Bergqvist A.G.C., Schall J.I., Gallagher P.R., Cnaan A., Stallings V.A.: Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia, 2005, 46: 1810–1819. doi: 10.1111/j.1528-1167.2005.00282.x

Bergqvist A.G.C., Schall J.I., Stallings V.A., Zemel B.S.: Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am. J. Clin. Nutr., 2008, 88: 1678–1684. doi: 10.3945/ajcn.2008.26099

Boison D.: New insights into the mechanism of the ketogenic diet. Curr. Opin. Neurol., 2017, 30: 187–192. doi: 10.1097/ WCO.0000000000000432.

Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G. et al: Mitochondrial Biogenesis in the Anticonvulsant Mechanism of the Ketogenic Diet. Ann. Neurol., 2006, 60: 223–235. doi: 10.1002/ana.20899

Bough K.J., Rho J.M.: Anitconvulsant Mechanism of the Ketogenic Diet. Epilepsia, 2007, 48: 43–58. doi: 10.1111/j.1528- 1167.2007.00915.x

Bruce S., Devlin A., Air L., Cook L.: Changes in quality of life as a result of ketogenic diet therapy: A new approach to assessment with the potential for positive therapeutic effects. Epilepsy Behav., 2017, 66: 100–104. doi: 10.1016/j.yebeh.2016.10.001.

Cai Q.Y., Zhou Z.J., Luo R., Gan J., Li S.P., Mu D.Z., Wan C.M.: Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J. Pediatr., 2017, 13: 528– 536. doi: 10.1007/s12519-017-0053-2.

Caraballo R.H.: Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia, 2011, 52 (Suppl. 2): 79–82. doi: 10.1111/j.1528-1167.2011.03009.x

Caraballo R.H., Cersósimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N.: Ketogenic diet in patients with Dravet syndrome. Epilepsia, 2005, 46: 1539–1544. doi: 10.1111/j.1528- 1167.2005.05705.x

Caraballo R.H., Cersósimo R.O., Sakr D., Cresta A., Escobal N., Fejerman N.: Ketogenic diet in patients with myoclonicastatic epilepsy. Epileptic Disord., 2006, 8: 151–155.

Caraballo R.H., Fortini S., Fresler S., Armeno M., Ariela A., Cresta A. et al.: Ketogenic diet in patients with Lennox-Gastaut syndrome. Seizure, 2014, 23: 751–755. doi: 10.1016/j.seizure.2014.06.005

Cervenka M.C., Henry B.J., Felton E.A., Patton K., Kossoff E.H.: Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges. Epilepsy Behav., 2016(a), 58: 61–68. doi: 10.1016/j.yebeh.2016.02.038

Cervenka M.C., Henry-Barron B.J., Kossoff E.H.: Is there a role for diet monotherapy in adult epilepsy? Epilepsy Behav. Case Rep., 2016(b), 7: 6–9. doi: 10.1016/j.ebcr.2016.09.005.

Cervenka M.C., Kossoff E.H.: Dietary treatment of intractable epilepsy. Continuum (Minneap Minn), 2013, 19 (3 Epilepsy): 756–766. doi: 10.1212/01.CON.0000431396.23852.56

Cervenka M.C., Patton K., Eloyan A., Henry B., Kossoff E.H.: The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr. Neurosci., 2016(c), 19: 131–137. doi: 10.1179/1476830514Y.0000000162

Chorągiewicz T., Żarnowska I., Gąsior M., Żarnowski T.: Przeciwdrgawkowe i neuroprotekcyjne działanie diety ketogennej. Przegl. Lek., 2010, 67: 205–212.

Cross J.H., Auvin S., Falip M., Striano P., Arzimanoglou A.: Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations. Front. Neurol., 2017, 8: 505. doi: 10.3389/fneur.2017.00505.

Cross J.H.: New research with diets and epilepsy. J. Child. Neurol., 2013, 28: 970–974. doi: 10.1177/0883073813487593

Curatolo P., Jóźwiak S., Nabbout R. on behalf of participants of the TSC Consensus Meeting for SEGA and Epilepsy Management.: Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur. J. Paediatr. Neurol., 2012, 16: 582–586. doi: 10.1016/j.ejpn.2012.05.004

Danial N.N., Hartman A.L., Stafstrom C.E., Thio L.L.: How does the ketogenic diet work? Four potential mechanisms. J. Child. Neurol., 2013, 28: 1027–1033. doi: 10.1177/0883073813487598

Dressler A., Haiden N., Trimmel-Schwahofer P., Benninger F., Samueli S., Gröppel G. et al: Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy. Epilepsia Open, 2018, 3: 30–39. doi: 10.1002/epi4.12084

Dressler A., Trimmel-Schwahofer P., Reithofer E., Gröppel G., Mühlebner A., Samueli S. et al: The ketogenic diet in infants – Advantages of early use. Epilepsy Res., 2015(a), 116: 53– 58. doi: 10.1016/j.eplepsyres.2015.06.015

Dressler A., Trimmel-Schwahofer P., Reithofer E., Mühlebner A., Gröppel G., Reiter-Fink E. et al.: Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen. Epilepsy Res., 2015(b), 109: 81–89. doi: 10.1016/j.eplepsyres.2014.10.014

Dulac O., Takahashi T.: Status epilepticus. Handb. Clin. Neurol., 2013, 111: 681–689. doi: 10.1016/B978-0-444-52891- 9.00070-1

Elamin M., Ruskin D.N., Masino S.A., Sacchettti P.: Ketonebased Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? Front. Mol. Neurosci., 2017, 10: 377. doi: 10.3389/ fnmol.2017.00377. Ketogenic diet in epilepsy: an updated review 40

Elia M., Klepper J., Leiendecker B., Hartmann H.: Ketogenic diets in the treatment of epilepsy. Curr. Pharm. Des., 2017, 23: 5691–5701. doi: 10.2174/1381612823666170809101517

El-Rashidy O.F., Nassar M.F., Abdel-Hamid I.A., Shatla R.H., Abdel-Hamid M.H., Gabr S.S. et al.: Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol. Scand., 2013, 128: 402–408. doi: 10.1111/ane.12137 Eun S.H. Kang H.C., Kim D.W., Kim H.D.: Ketogenic diet for treatment of infantile spasms. Brain Dev., 2006, 28: 566–571. doi: 10.1016/j.braindev.2006.03.011

Farias-Moeller R., Bartolini L., Pasupuleti A., Cines R.D.B., Kao A., Carpenter J.L.: A practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus. Neurocrit Care, 2017, 26: 267–272. doi: 10.1007/ s12028-016-0312-4

Fliciński J., Starczewska M., Steinborn B.: Wtórne niedobory i możliwości suplementacji L-karnityny w praktyce neurologa. Neurol. Dziec., 2016, 25: 29–38. doi: 10.20966/chn.2016.51.382

Freeman J.M., Vining E.P., Kossoff E.H., Pyzik P.L., Ye X., Goodman S.N.: A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 322–325. doi: 10.1111/j.1528-1167.2008.01740.x

Freeman J.M., Vining E.P., Pillas D.J., Pyzik P.L., Casey J.C., Kelly M.T.: The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics, 1998, 102: 1358–1363. doi: 10.1542/peds.102.6.1358

French J.A., Koepp M., Naegelin Y., Vigevano F., Auvin S., Rho J.M. et al.: Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia, 2017 (Suppl. 58), 3: 69–82. doi: 10.1111/epi.13779

Gaspard N., Hirsch L.J., Sculier C., Loddenkemper T., van Baalen A., Lancrenon J. et al.: New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia, 2018, 59: 745–752. doi: 10.1111/epi.14022

Greco T., Glenn T.C., Hovda D.A., Prins M.L.: Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity. J. Cereb. Blood Flow Metab., 2016, 36: 1603–1613. doi: 10.1177/0271678X15610584

Groesbeck D.K., Bluml R.M., Kossoff E.H.: Long-term use of the ketogenic diet in the treatment of epilepsy. Dev. Med. Child. Neurol., 2006, 48: 978–981. doi: 10.1017/S0012162206002143

Groomes L.B., Pyzik P.L., Turner Z., Dorward J.L., Goode V.H., Kossoff E.H.: Do Patients With Absence Epilepsy Respond to Ketogenic Diets? J. Child. Neurol., 2011, 26: 160–165. doi: 10.1177/0883073810376443

Hallböök T., Lundgren J., Rosén I.: Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia, 2007, 48: 59–65.

Hallböök T., Ji S., Maudsley S., Martin B.: The effects of the ketogenic diet on behavior and cognition. Epilepsy Res., 2012, 100: 304–309. doi: 10.1016/j.eplepsyres.2011.04.017 Hartman A.L., Vining E.P.G: Clinical Aspects of the Ketogenic Diet. Epilepsia, 2007, 48: 31–42. doi: 10.1111/j.1528- 1167.2007.00914.x

Hemingway C., Freeman J.M., Pillas D.J., Pyzik P.L.: The ketogenic diet: a 3- to 6-year follow up of 150 children enrolled prospectively. Pediatrics, 2001, 108: 898–905.

Henderson C.B., Filloux F.M., Alder S.C., Lyon J., Caplin D.A.: Efficacy of the Ketogenic Diet as a Treatment Option for Epilepsy: Meta-analysis. J. Child. Neurol., 2006, 21: 193–198.

Heo G., Kim S.H., Chang M.J.: Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy. J. Clin. Pharm. Ther., 2017, 42: 758–764. doi: 10.1111/jcpt.12578

Hong A.M., Turner Z., Hamdy R.F., Kossoff E.H.: Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia, 2010, 51: 1403–1407.

IJff D.M., Postulart D., Lambrechts D.A.J.E., Majoie M.H.J.M., de Kinderen R.J.A., Hendriksen J.G.M. et al.: Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav., 2016, 60: 153–157. doi: 10.1016/j. yebeh.2016.04.033

Jung D.E., Kang H.C., Kim H.D.: Long-term outcome of the ketogenic diet for intractable childhood epilepsy with focal malformation of cortical development. Pediatrics, 2008, 122: e330– e333. doi: 10.1542/peds.2008-0012

Kang H.C., Chung D.E., Kim D.W., Kim H.D.: Early and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia, 2004, 45: 1116–1123. doi: 10.1111/j.0013- 9580.2004.10004.x

Kang H.C., Lee Y.J., Lee J.S., Eom S.J., You S.J., Kim H.D.: Comparison of short-versus long-term ketogenic diet for intractable infantile spasm. Epilepsia, 2011, 52: 781–787.

Kang H.C., Kim Y.J., Kim D.W., Kim H.D.: Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia, 2005, 46: 272–279. doi: 10.1111/j.0013-9580.2005.48504.x

Kayyali H.R., Gustafson M., Myers T., Thompson L., Williams M., Abdelmoity A.: Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Pediatr. Neurol., 2014, 50: 224–227. doi: 10.1016/j.pediatrneurol.2013.11.021

Kayyali H.R., Luniova A., Abdelmoity A.: Ketogenic Diet decreases Emergency Room Visits and Hospitalizations Related to Epilepsy. Epilepsy Res. Treat., 2016: 5873208. doi: 10.1155/2016/5873208

Magdalena Dudzińska 41 Keene D.L.: A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr. Neurol., 2006, 35: 1–5. doi: 10.1016/j.pediatrneurol.2006.01.005

Kessler S.K., Gallagher P.R., Shellhaas R.A., Clancy R.R., Bergqvist A.G.: Early EEG improvement after ketogenic diet initiation. Epilepsy Res., 2011, 94: 94–101. doi: 10.1016/j.eplepsyres.2011.01.012

Kilaru S., Bergqvist A.G.C.: Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia, 2007, 48: 1703–1707. doi: 10.1111/j.1528-1167.2007.01186.x

Kim D.W., Kang H.C., Park J.C., Kim H.D.: Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics, 2004, 114: 1627–1630. doi: 10.1542/ peds.2004-1001

Kim J.A., Yoon J.R., Lee E.J., Lee J.S., Kim J.T., Kim H.D., Kang H.C.: Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia, 2016, 57: 51–58. doi: 10.1111/epi.13256

de Kinderen R.J., Lambrechts D.A., Postulart D., Kessels A.G., Hendriksen J.G., Aldenkamp A.P. et al.: Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurol., 2011, 11: 10.

de Kinderen  R.J., Lambrechts D.A., Wijnen B.F., Postulart D., Aldenkamp A.P., Majoie M.H., Evers S.M.: An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis. Epilepsia, 2016, 57: 41–50.

de Kinderen  R.J., Postulart D., Aldenkamp A.P., Evers S.M., Lambrechts D.A., Louw A.J. et al.: Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy. Epilepsy Res., 2015, 110: 119–131. doi: 10.1016/j.eplepsyres.2014.12.005

Kinsman S.L., Vining E.P., Quaskey S.A., Mellits D., Freeman J.M.: Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia, 1992, 33: 1132–1136.

Klein P., Janousek J., Barber A., Weissberger R.: Ketogenic diet in adults with refractory epilepsy. Epilepsy Behav., 2010, 19: 575–579. doi: 10.1016/j.yebeh.2010.09.016

Klepper J., Leiendecker B., Bredhal R., Athanassopoulos S., Heinen, F., Gertsen E. et al: Introduction of a ketogenic diet in young infants. J. Inherit. Metab. Dis., 2002, 25: 449–460.

Klepper J., Leiendecker B.: GLUT 1 deficiency syndrome-2007 update. Dev. Med. Child. Neurol., 2007, 49: 707–716. doi: 10.1111/j.1469-8749.2007.00707.x

Kose E., Guzel O., Arslan N.: Analysis of hematological parameters in patients treated with ketogenic diet due to drugresistant epilepsy. Neurol. Sci., 2018, 39: 85–89. doi: 10.1007/ s10072-017-3152-x.

Kossoff E.H., Dorward J.L.: The Modified Atkins Diet. Epilepsia, 2008, 49 (Suppl. 8): 37–41. doi: 10.1111/j.1528- 1167.2008.01831.x

Kossoff E.H., Hedderick E.F., Turner Z., Freeman J.M.: A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms. Epilepsia, 2008a, 49: 1504–1509. doi: 10.1111/j.1528-1167.2008.01606.x

Kossoff E.H., Laux L.C., Blackford R., Morrison P.F., Pyzik P.L., Hamdy R.M. et al.: When do seizures usually improve with the ketogenic diet? Epilepsia, 2008b, 49: 329–333. doi: 10.1111/j.1528-1167.2007.01417.x

Kossoff E.H., Nabbout R.: Use of dietary therapy for status epilepticus. J. Child. Neurol., 2013, 28: 1049-1051. doi: 10.1177/0883073813487601

Kossoff E.H., Pyzik P.L., McGrogan J.R., Vining E.P., Freeman J.M.: Efficacy of the Ketogenic Diet for Infantile Spasms. Pediatrics, 2002, 109: 780–783. doi: 10.1542/peds.109.5.780

Kossoff E.H., Thiele E.A., Pfeifer H.H., McGrogan J.R., Freeman J.M.: Tuberous sclerosis complex and the ketogenic diet. Epilepsia, 2005, 46: 1684–1686. doi: 10.1111/j.1528- 1167.2005.00266.x

Kossoff E.H., Turner Z., Bluml R.M., Pyzik P.L., Vining E.P.G.: A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav., 2007, 10: 432– 436. doi: 10.1016/j.yebeh.2007.01.012

Kossoff E.H., Wang H.S.: Dietary therapies for epilepsy. Biomed J., 2013, 36: 2–8. doi: 10.4103/2319-4170.107152

Kossoff E.H., Zupec-Kania B.A., Amark P.E., Ballaban-Gil K.R., Bergqvist C.A.G., Blackford R. et al.: Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia, 2009a, 50: 304–317. doi: 10.1111/j.1528-1167.2008.01765.x

Kossoff E.H., Zupec-Kania B.A., Rho J.M.: Ketogenic Diets: An Update for Child Neurologists. J Child Neurol, 2009b, 24: 979–988. doi: 10.1177/0883073809337162

Kramer U., Chi C.S., Lin K.L., Specchio N., Sahin M., Olson H. et al.: Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia, 2011, 52: 1956–1965. doi: 10.1111/j.1528- 1167.2011.03250.x

Kwan P., Arzimanoglou A., Berg A.T., Brodie M. J., Hauser A.W., Mathern G. et al: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 2010, 51: 1069– 1077. doi: 10.1111/j.1528-1167.2009.02397.x

Lambrechts D.A., de Kinderen R.J., Vles J.S., de Louw A.J., Aldenkamp A.P., Majoie H.J.: A randomized controlled trial of Ketogenic diet in epilepsy: an updated review 42 the ketogenic diet in refractory childhood epilepsy. Acta Neurol. Scand., 2017, 135: 231–239. doi: 10.1111/ane.12592.

Lee J., Lee J.H., Yu H.J., Lee M.: Prognostic factors of infantile spasms: role of treatment options including a ketogenic diet. Brain Dev., 2013, 35: 821–826. doi: 10.1016/j.braindev.2013.06.014

Lee M.: The use of ketogenic diet in special situations: expanding use in intractable epilepsy and other neurologic disorders. Korean J. Pediatr., 2012, 55: 316–321. doi: 10.3345/kjp.2012.55.9.316

Lefevre F., Aronson N.: Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics, 2000, 105: E46.

Lemmon M.E., Terao N.N., Ng Y.T., Reisig W., Rubenstein J.E., Kossoff E.H.: Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literature. Dev. Med. Child. Neurol., 2012, 54: 464–468. doi: 10.1111/j.1469-8749.2012.04233.x

Levy R., Cooper P.: Ketogenic diet for epilepsy. Cochrane Database Syst. Rev., 2003, 3: CD001903. doi: 10.1002/14651858. CD001903

Li B., Tong L., Jia G., Sun R.: Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy. Exp. Ther. Med., 2013a, 5: 611– 615. doi: 10.3892/etm.2012.823

Li H.F., Zou Y., Ding G.: Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis. Iran J. Pediatr., 2013b, 23: 613–620.

Lin A., Turner Z., Doerrer S.C., Stanfield A., Kossoff E.H.: Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes. Pediatr. Neuro., 2017, 68: 35–39. doi: 10.1016/j.pediatrneurol.2017.01.007

Luat A.F., Coyle L., Kamat D.: The Ketogenic Diet: A Practical Guide for Pediatricians. Pediatr. Ann., 2016, 45: e446-e450. doi: 10.3928/19382359-20161109-01

Lyczkowski D.A., Pfeifer H.H., Ghosh S., Thiele E.A.: Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Epilepsia, 2005, 46: 1533– 1538. doi: 10.1111/j.1528-1167.2005.22705.x

Maalouf M., Rho J.M., Mattson M.P.: The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev., 2009, 59: 293–315. doi: 10.1016/j.brainresrev.2008.09.002

Martin K., Jackson C.F., Levy R.G., Cooper P.N.: Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev., 2016, 2:CD001903. doi: 10.1002/14651858. CD001903.pub3.

Martin-McGill K.J., Jenkinson M.D., Tudur Smith C., Marson A.G.: The modified ketogenic diet for adults with refractory epilepsy: An evaluation of a set up service. Seizure, 2017, 52: 1–6. doi: 10.1016/j.seizure.2017.08.013

Masino S.A., Rho J.M.: Mechanisms of Ketogenic Diet Action. In: J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (eds.), SourceJasper’s Basic Mechanisms of the Epilepsies [Internet]. 4th ed., Bethesda (MD): National Center for Biotechnology Information (US), 2012. Mastrangelo M.: Lennox-Gastaut Syndrome: A State of the Art Review. Neuropediatrics, 2017, 48: 143–151. doi: 10.1055/s0037-1601324

McArtney R., Bailey A., Champion H.: What is a ketogenic diet and how does it affect the use of medicines? Arch. Dis. Child. Educ. Pract. Ed., 2017, 102: 194–199. doi: 10.1136/ archdischild-2014-307000

McDaniel S.S., Rensing N.R., Thio L.L., Yamada K.A., Wong M.: The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia, 2011, 52: e7–e11. doi: 10.1111/ j.1528-1167.2011.02981

McNally M.A., Pyzik P.L., Rubenstein J.E., Hamdy R.F., Kossoff E.H.: Empiric use of potassium citrate reduces kidney stone incidence with the ketogenic diet. Pediatrics, 2009, 124: e300– e304. doi: 10.1542/peds.2009-0217

Mc Tague A., Cross J.H.: Treatment of Epileptic Encephalopathies. CNS Drugs, 2013, 27: 175–184. doi: 10.1007/s40263- 013-0041-6

Mohanraj R., Brodie M.J.: Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur. J. Neurol., 2006, 13: 277–282. doi: 10.1111/j.1468-1331.2006.01215.x

Moriyama K., Watanabe M., Yamada Y., Shiihara T.: Protein-losing enteropathy as a rare complication of the ketogenic diet. Pediatr. Neurol., 2015, 52: 526–528. doi: 10.1016/j.pediatrneurol.2015.01.009

Morrison P.F., Pyzik P.L., Hamdy R., Hartman A.L., Kossoff E.H.: The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia, 2009, 50: 1999–2001. doi: 10.1111/j.1528-1167.2009.02053.x

Mullen S.A., Marini C., Suls A., Mei D., Della Giustina E., Buti D. et al.: Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch. Neurol., 2011, 68: 1152–1155. doi:10.1001/archneurol.2011.102

Nabbout R., Camfield C.S., Andrade D.M., Arzimanoglou A., Chiron C., Cramer J.A. et al.: Treatment issues for children with epilepsy transitioning to adult care. Epilepsy Behav., 2017, 69: 153–160. doi: 10.1016/j.yebeh.2016.11.008.

Nabbout R., Copioli C., Chipaux M., Chemaly N., Desguerre I., Dulac O., Chiron C.: Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study. Epilepsia, 2011, 52: e54–e57. doi: 10.1111/j.1528- 1167.2011.03107.x Magdalena Dudzińska 43

Nabbout R., Mazzuca M., Hubert P., Peudennier S., Allaire C., Flurin V. et al: Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia, 2010, 51: 2033–2037. doi: 10.1111/j.1528-1167.2010.02703.x

Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G. et al: The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol., 2008, 7: 500–506. doi: 10.1016/S1474-4422(08)70092-9

Newell C., Bomhof M.R., Reimer R.A., Hittel D.S., Rho J.M., Shearer J.: Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Mol. Autism, 2016, 7: 37. doi: 10.1186/s13229-016-0099-3.

Nizamuddin J., Turner Z., Rubenstein J.E., Pyzik P.L., Kossoff E.H.: Management and Risk Factors for Dyslipidemia With the Ketogenic Diet. J. Child. Neurol., 2008, 23: 758–761. doi: 10.1177/0883073808318061

Nunes V.D., Sawyer L., Neilson J., Sarri G., Cross J.H.: Diagnosis and management of epilepsies in adults and children: summary of updated NICE guidance. BMJ, 2012, 344: e281. doi: 10.1136/bmj.e281.

Nordli D.R. Jr, Kuroda M.M., Carroll J., Koenigsberger D.Y., Hirsch L.J., Bruner H.J. et al.: Experience with the ketogenic diet in infants. Pediatrics, 2001, 108: 129–133.

Ozdemir R., Kucuk M., Guzel O., Karadeniz C., Yilmaz U., Mese T.: Does ketogenic diet have any negative effect on cardiac systolic and diastolic functions in children with intractable epilepsy?: One-year follow-up results. Brain Dev., 2016, 38: 842– 847. doi: 10.1016/j.braindev.2016.03.009

Palmer S., Towne M.C., Pearl P.L., Pelletier R.C., Genetti C.A., Shi J. et al: SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures. Pediatr. Neurol., 2016, 64: 77–79. doi: 10.1016/j.pediatrneurol.2016.07.012

Park S., Lee E.J, Eom S., Kang H.C., Lee J.S., Kim H.D.: Ketogenic Diet for the management of Epilepsy Associated with Tuberous Sclerosis Complex in Children. J. Epilepsy Res., 2017, 7: 45–49. doi: 10.14581/jer.17008.

Pascal L., Caraballo R.H., De Giorgis V., Reyes J.G., Macasaet J.A., Masnada S. et al.: Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two-centre experience. Seizure, 2018, 57: 34–37. doi: 10.1016/j.seizure.2018.03.005.

Patel A., Pyzik P.L., Turner Z., Rubenstein J.E., Kossoff E.H.: Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia, 2010, 51: 1277–1282. doi: 10.1111/j.1528- 1167.2009.02488.x

Paul E., Conant K.D. Dunne I.E., Pfeifer H.H., Lyczkowski D.A., Linshaw M.A., Thiele E.A.: Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res., 2010, 90: 151–156. doi: 10.1016/j.eplepsyres.2010.04.005

Pires M.E., Ilea A., Bourel E., Bellavoine V., Merdariu D., Berquin P., Auvin S.: Ketogenic diet for infantile spasms refractory to first-line treatments: an open prospective study. Epilepsy Res., 2013, 105: 189–194.